SW3-26447-96403
3 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 440 / OH
- Registered
- 2021-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-10-15
Dose 1 — Moderna
-
2021-11-12
Dose 2 — Moderna
-
2021-12-22
Registered in v-safe
- 2021-12-23
- 2021-12-24
-
2022-02-11
Survey response — 3 months, dose 2MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: GoodFree text: Headache, congestion, runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-05-15
-
2022-07-20
Dose 3 — Moderna
- 2022-07-21
- 2022-07-22
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-08-03
- 2022-08-10
- 2022-08-17
- 2022-08-24
- 2022-08-31
- 2022-10-19
- 2023-01-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-10-15 | Moderna | No |
| 2 | 2021-11-12 | Moderna | No |
| 3 | 2022-07-20 | Moderna | No |
Free text
Release 11 — 3 months, dose 2
Symptoms: Headache, congestion, runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release